Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium

被引:310
|
作者
Goldgur, Y [1 ]
Dyda, F [1 ]
Hickman, AB [1 ]
Jenkins, TM [1 ]
Craigie, R [1 ]
Davies, DR [1 ]
机构
[1] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1073/pnas.95.16.9150
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 integrase is an essential enzyme in the life cycle of the virus, responsible for catalyzing the insertion of the viral genome into the host cell chromosome; it provides an attractive target for antiviral drug design. The previously reported crystal structure of the HIV-1 integrase core domain revealed that this domain belongs to the superfamily of polynucleotidyltransferases. However, the position of the conserved catalytic carboxylic acids differed from those observed in other enzymes of the class, and attempts to crystallize in the presence of the cofactor, Mg2+, were unsuccessful. We report here three additional crystal structures of the core domain of HIV-1 integrase mutants, crystallized in the presence and absence of cacodylate, as well as complexed with Mg2+. These three crystal forms, containing between them seven independent core domain structures, demonstrate the unambiguous extension of the previously disordered helix alpha 4 toward the amino terminus from residue M154 and show that the catalytic E152 points in the general direction of the two catalytic aspartates, D64 and D116, In the vicinity of the active site, the structure of the protein in the absence of cacodylate exhibits significant deviations from the previously reported structures. These differences can be attributed to the modification of C65 and C130 by cacodylate, which was an essential component of the original crystallization mixture. We also demonstrate that in the absence of cacodylate this protein will bind to Mg2+, and could provide a satisfactory platform for binding of inhibitors.
引用
收藏
页码:9150 / 9154
页数:5
相关论文
共 50 条
  • [21] HIV-1 integrase crosslinked oligomers are active in vitro
    Faure, A
    Calmels, C
    Desjobert, C
    Castroviejo, M
    Caumont-Sarcos, A
    Tarrago-Litvak, L
    Litvak, S
    Parissi, V
    NUCLEIC ACIDS RESEARCH, 2005, 33 (03) : 977 - 986
  • [22] A potent and orally active HIV-1 integrase inhibitor
    Egbertson, Melissa S.
    Moritz, H. Marie
    Melamed, Jeffrey Y.
    Han, Wei
    Perlow, Debra S.
    Kuo, Michelle S.
    Embrey, Mark
    Vacca, Joseph P.
    Zrada, Matthew M.
    Cortes, Amanda R.
    Wallace, Audrey
    Leonard, Yvonne
    Hazuda, Daria J.
    Miller, Michael D.
    Felock, Peter J.
    Stillmock, Kara A.
    Witmer, Marc V.
    Schleif, William
    Gabryelski, Lori J.
    Moyer, Gregory
    Ellis, Joan D.
    Jin, Lixia
    Xu, Wei
    Braun, Matthew P.
    Kassahun, Kellem
    Tsou, Nancy N.
    Young, Steven D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1392 - 1398
  • [23] Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor:: High level of similarity of the active site with other viral integrases
    Maignan, S
    Guilloteau, JP
    Zhou-Liu, Q
    Clément-Mella, C
    Mikol, V
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 282 (02) : 359 - 368
  • [24] An Unusual Helix Turn Helix Motif in the Catalytic Core of HIV-1 Integrase Binds Viral DNA and LEDGF
    Merad, Hayate
    Porumb, Horea
    Zargarian, Loussine
    Rene, Brigitte
    Hobaika, Zeina
    Maroun, Richard G.
    Mauffret, Olivier
    Fermandjian, Serge
    PLOS ONE, 2009, 4 (01):
  • [25] HIV-1 INTEGRASE INHIBITORS - 3D SEARCHING AND ACTIVE-SITE DOCKING
    NICKLAUS, MC
    POMMIER, Y
    MAZUMDER, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 22 - CINF
  • [26] Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase
    Gupta, Pawan
    Kumar, Rajender
    Garg, Prabha
    Singh, Inder Pal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4427 - 4431
  • [27] Identification of a monoclonal antibody binding site of HIV-1 integrase
    Yi, JZ
    Skalka, AM
    FASEB JOURNAL, 1999, 13 (07): : A1503 - A1503
  • [28] Molecular dynamics studies on the HIV-1 integrase catalytic domain
    Lins, RD
    Briggs, JM
    Straatsma, TP
    Carlson, HA
    Greenwald, J
    Choe, S
    McCammon, JA
    BIOPHYSICAL JOURNAL, 1999, 76 (06) : 2999 - 3011
  • [29] The active site of HIV-1 protease
    Mager, PP
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 348 - 353
  • [30] Measuring rapid hydrogen exchange in the homodimeric 36 kDa HIV-1 integrase catalytic core domain
    Fitzkee, Nicholas C.
    Torchia, Dennis A.
    Bax, Ad
    PROTEIN SCIENCE, 2011, 20 (03) : 500 - 512